Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hammerschmidt

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Kidney International|March 1, 1984
Protein loss induced by complement activation during peritoneal dialysisF N Miller, D E Hammerschmidt, G L Anderson, et al.
JAMA|July 11, 1980
A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.
The New England Journal of Medicine|April 3, 1980
Complement-induced granulocyte aggregation: an unsuspected mechanism of diseaseH S Jacob, P R Craddock, D E Hammerschmidt, et al.
JAMA|May 1, 1987
Leukocytes and the risk of ischemic diseasesE Ernst, D E Hammerschmidt, U Bagge, et al.
Transactions of the Association of American Physicians|January 1, 1979
Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosisC S Greenberg, D E Hammerschmidt, P R Craddock, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1981
Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injuryD J Weisdorf, D E Hammerschmidt, H S Jacob, et al.
Blood|May 1, 1988
Lymphocyte aggregation in response to adrenergic stimulationD E Hammerschmidt, C Jeanneret, M Husak, et al.
The Journal of Clinical Investigation|July 1, 1981
Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitroK M Skubitz, P R Craddock, D E Hammerschmidt, et al.
JAMA|March 12, 1982
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shockR J Xiu, D E Hammerschmidt, P A Coppo, et al.
Inflammation|September 1, 1982
Influence of dietary omega-3 fatty acids on granulocyte functionC J Lammi-Keefe, D E Hammerschmidt, D J Weisdorf, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Kidney International|March 1, 1984
Protein loss induced by complement activation during peritoneal dialysisF N Miller, D E Hammerschmidt, G L Anderson, et al.
JAMA|July 11, 1980
A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.
The New England Journal of Medicine|April 3, 1980
Complement-induced granulocyte aggregation: an unsuspected mechanism of diseaseH S Jacob, P R Craddock, D E Hammerschmidt, et al.
JAMA|May 1, 1987
Leukocytes and the risk of ischemic diseasesE Ernst, D E Hammerschmidt, U Bagge, et al.
Transactions of the Association of American Physicians|January 1, 1979
Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosisC S Greenberg, D E Hammerschmidt, P R Craddock, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1981
Rapid in vivo clearance of C5ades arg: a possible protective mechanism against complement-mediated tissue injuryD J Weisdorf, D E Hammerschmidt, H S Jacob, et al.
Blood|May 1, 1988
Lymphocyte aggregation in response to adrenergic stimulationD E Hammerschmidt, C Jeanneret, M Husak, et al.
The Journal of Clinical Investigation|July 1, 1981
Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitroK M Skubitz, P R Craddock, D E Hammerschmidt, et al.
JAMA|March 12, 1982
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shockR J Xiu, D E Hammerschmidt, P A Coppo, et al.
Inflammation|September 1, 1982
Influence of dietary omega-3 fatty acids on granulocyte functionC J Lammi-Keefe, D E Hammerschmidt, D J Weisdorf, et al.
Pageof 12